Top Page
Terragen Holdings Ltd
(Sydney:TGH)
Terragen Holdings Ltd (TGH) vs. iShares MSCI Australia ETF (EWA)
Terragen Holdings Ltd Business Overview & Revenue Model
Terragen Holdings Ltd Financial Statement Overview
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.38M | 1.62M | 2.14M | 3.28M | 2.89M | 3.65M |
| Gross Profit | 583.15K | 792.23K | 2.06M | 3.21M | 2.62M | 3.19M |
| EBITDA | -3.82M | -4.68M | -3.50M | -3.46M | -5.67M | -6.13M |
| Net Income | -3.20M | -3.72M | -3.01M | -3.23M | -5.41M | -6.10M |
Balance Sheet | ||||||
| Total Assets | 5.84M | 8.12M | 6.95M | 6.35M | 9.22M | 14.72M |
| Cash, Cash Equivalents and Short-Term Investments | 2.82M | 4.81M | 4.54M | 4.17M | 6.67M | 11.64M |
| Total Debt | 483.87K | 735.45K | 542.23K | 239.37K | 332.26K | 357.96K |
| Total Liabilities | 1.07M | 1.55M | 1.63M | 1.27M | 1.46M | 1.70M |
| Stockholders Equity | 4.78M | 6.57M | 5.32M | 5.08M | 7.76M | 13.02M |
Cash Flow | ||||||
| Free Cash Flow | -3.59M | -3.03M | -2.35M | -2.91M | -4.97M | -4.93M |
| Operating Cash Flow | -3.55M | -3.03M | -2.32M | -2.81M | -4.80M | -4.52M |
| Investing Cash Flow | -661.04K | -682.43K | -132.93K | -35.20K | -118.20K | -408.02K |
| Financing Cash Flow | 932.53K | 3.87M | 2.82M | 351.00K | -52.70K | 194.92K |
Terragen Holdings Ltd Technical Analysis
Terragen Holdings Ltd Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
52 Neutral | AU$27.94M | -6.64 | -25.50% | ― | -100.00% | -182.93% | |
46 Neutral | AU$7.91M | -1.39 | -217.79% | ― | ― | 43.46% | |
43 Neutral | AU$28.57M | -3.96 | -41.21% | ― | 140.94% | 88.59% | |
43 Neutral | AU$10.40M | -1.09 | -390.08% | ― | ― | 19.94% | |
39 Underperform | AU$11.99M | -3.02 | -62.66% | ― | -24.42% | -2.30% |
Terragen Holdings Ltd Corporate Events
Terragen Holdings has released an independent commercial-scale assessment showing its Great Land Plus biostimulant increased maize silage yields by up to 12 percent over standard grower practice. The trial, conducted by on-farm trial specialist Laconik in New South Wales, found the recommended 4 L/ha application rate outperformed lower doses and combinations with kelp extract.
Using prevailing Australian silage maize values, Terragen estimated the yield uplift equates to about $1,100 in additional gross revenue per hectare. With total treatment and application costs of $55 per hectare, the company calculates a potential return on investment of up to 20 times, reinforcing GLP’s positioning as a cost-effective tool for boosting productivity and supporting soil health.
The 13 replicated data sets across multiple blocks delivered statistically significant results for the 4 L/ha GLP treatment, while lower rates and kelp combinations showed no significant advantage over untreated controls. Terragen says the findings should give growers greater confidence to adopt GLP in silage maize production and potentially improve farm profitability under comparable conditions.
The most recent analyst rating on (AU:TGH) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Terragen Holdings Ltd stock, see the AU:TGH Stock Forecast page.
Terragen Holdings Limited has called a virtual general meeting for shareholders to be held on 25 March 2026 at 10:00am Melbourne time, with access provided via an online meeting link and associated digital materials. The company is moving to primarily electronic distribution of its Notice of General Meeting and Explanatory Memorandum, in line with Corporations Act provisions, while still allowing investors to request hard copies or seek assistance from the company secretary or share registry.
Shareholders are being strongly encouraged to lodge directed proxy forms by 23 March 2026 and to submit questions ahead of the meeting so management can prepare responses. The arrangements underscore Terragen’s focus on increasing digital engagement and administrative efficiency in its shareholder communications, which may facilitate broader participation while reducing reliance on physical documentation.
The most recent analyst rating on (AU:TGH) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Terragen Holdings Ltd stock, see the AU:TGH Stock Forecast page.
Terragen Holdings Limited has lodged a notice with the ASX for a proposed placement of up to 191,927,526 new fully paid ordinary shares, to be issued on 30 March 2026, under its existing listing framework. The sizeable equity issuance, once completed, will materially expand the company’s share base and is expected to provide additional capital for its operations or strategic initiatives, with implications for existing shareholders through potential dilution and for the market through an increased free float in TGH securities.
The most recent analyst rating on (AU:TGH) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Terragen Holdings Ltd stock, see the AU:TGH Stock Forecast page.
Terragen Holdings Ltd has announced a proposed placement of up to 126,254,293 new fully paid ordinary shares, to be issued on 16 February 2026, subject to ASX processes. The capital raising signals a significant equity issuance that could alter the company’s capital structure and shareholder dilution profile, positioning Terragen to access new funding for its operations or strategic initiatives while investors await further detail on pricing and use of proceeds.
The most recent analyst rating on (AU:TGH) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Terragen Holdings Ltd stock, see the AU:TGH Stock Forecast page.
Terragen Holdings Limited has requested and been granted a trading halt on its shares on the ASX as it prepares to announce a material institutional placement, signalling an imminent capital raise. The halt will remain in place until either the start of trading on 6 February 2026 or the release of the capital-raising announcement, indicating that Terragen is seeking to strengthen its balance sheet and potentially fund further growth or operational initiatives, with near‑term implications for existing shareholders and the company’s capital structure.
The most recent analyst rating on (AU:TGH) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Terragen Holdings Ltd stock, see the AU:TGH Stock Forecast page.
Terragen reported strong momentum in its Terragen Probiotic for Ruminants (TPR) business, highlighted by a large-scale assessment with Mort & Co at Australia’s largest single-site beef feedlot covering more than 10,000 head, alongside an 87% quarter-on-quarter increase in TPR sales since its April 2025 launch. The company advanced global market access with regulatory trial permits in Canada, ongoing approvals in Brazil and Canada, and negotiations with a global nutrition group for North American manufacturing and distribution, while drought and weak dairy trading conditions weighed on total sales; meanwhile, its Great Land Plus soil product delivered leading tomato yields in commercial trials, companion animal formulations moved into pilot-scale production, and lamb feedlot usage of TPR expanded through confirmed ongoing dosing commitments and new producer-led demonstrations.
The most recent analyst rating on (AU:TGH) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Terragen Holdings Ltd stock, see the AU:TGH Stock Forecast page.
Terragen Holdings Ltd, listed on the ASX under code TGH, has reported a change in its issued capital structure. The company has confirmed that 5 million options, previously on issue and exercisable at A$1.00 with an expiry date of 4 December 2025, have lapsed unexercised as of that date. The expiry of these options without conversion reduces the potential future dilution of existing shareholders and marginally simplifies Terragen’s capital structure, although it does not directly affect current issued share capital or provide new funding to the company.
The most recent analyst rating on (AU:TGH) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on Terragen Holdings Ltd stock, see the AU:TGH Stock Forecast page.
Terragen Holdings Limited has announced the expiry of 2,000,000 unexercised options (ASX code TGHAU) that were due to expire on 4 December 2025 with an exercise price of A$0.50. The lapse of these options slightly reduces the company’s potential future share dilution but has no immediate impact on its existing issued capital, reflecting a routine adjustment to its capital structure rather than a change in underlying operations.
The most recent analyst rating on (AU:TGH) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on Terragen Holdings Ltd stock, see the AU:TGH Stock Forecast page.
Terragen Holdings Limited has confirmed the expiry of a tranche of unexercised options listed on the ASX. The company reported that 1,000,000 options, exercisable at A$0.25 and due to expire on 4 December 2025 under the code TGHAT, have lapsed without being converted into shares, resulting in a reduction of potential future dilution for existing shareholders but no immediate change to the company’s issued capital.
The most recent analyst rating on (AU:TGH) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on Terragen Holdings Ltd stock, see the AU:TGH Stock Forecast page.
Terragen Holdings Limited has confirmed the expiry of a tranche of unexercised options listed on the ASX. The company reported that 1,000,000 options, exercisable at A$0.25 and due to expire on 4 December 2025 under the code TGHAT, have lapsed without being converted into shares, resulting in a reduction of potential future dilution for existing shareholders but no immediate change to the company’s issued capital.
The most recent analyst rating on (AU:TGH) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on Terragen Holdings Ltd stock, see the AU:TGH Stock Forecast page.
Terragen Holdings Limited has received a $989,242 R&D tax incentive from the Australian Taxation Office for the 2024/2025 financial year, which will bolster their cash reserves and support ongoing commercialisation and development efforts. This incentive underscores Terragen’s commitment to advancing its position in the agricultural industry by investing in innovative solutions that enhance productivity and environmental outcomes, benefiting stakeholders and contributing to agricultural decarbonisation.
The most recent analyst rating on (AU:TGH) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on Terragen Holdings Ltd stock, see the AU:TGH Stock Forecast page.
Terragen Holdings Limited has updated its Securities Trading Policy to align with Listing Rule 12.10, reflecting good corporate governance practices. The revisions include clearer guidelines for employee access to sensitive information, updated closed periods to coincide with the release of the Appendix 4C report, and the inclusion of the Chairman in the prior notification clause. These changes are part of Terragen’s commitment to maintaining transparency and compliance, potentially impacting how stakeholders interact with the company’s securities.
The most recent analyst rating on (AU:TGH) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on Terragen Holdings Ltd stock, see the AU:TGH Stock Forecast page.